UnitedHealth Group (Brazil) Performance
UNHH34 Stock | 39.53 0.52 1.33% |
The entity has a beta of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, UnitedHealth Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding UnitedHealth Group is expected to be smaller as well. At this point, UnitedHealth Group has a negative expected return of -0.43%. Please make sure to validate UnitedHealth Group's treynor ratio, potential upside, and the relationship between the total risk alpha and maximum drawdown , to decide if UnitedHealth Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days UnitedHealth Group Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Begin Period Cash Flow | 21.4 B |
UnitedHealth |
UnitedHealth Group Relative Risk vs. Return Landscape
If you would invest 5,231 in UnitedHealth Group Incorporated on December 1, 2024 and sell it today you would lose (1,278) from holding UnitedHealth Group Incorporated or give up 24.43% of portfolio value over 90 days. UnitedHealth Group Incorporated is generating negative expected returns and assumes 2.5679% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than UnitedHealth, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
UnitedHealth Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for UnitedHealth Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as UnitedHealth Group Incorporated, and traders can use it to determine the average amount a UnitedHealth Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1656
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | UNHH34 |
Estimated Market Risk
2.57 actual daily | 22 78% of assets are more volatile |
Expected Return
-0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average UnitedHealth Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UnitedHealth Group by adding UnitedHealth Group to a well-diversified portfolio.
UnitedHealth Group Fundamentals Growth
UnitedHealth Stock prices reflect investors' perceptions of the future prospects and financial health of UnitedHealth Group, and UnitedHealth Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on UnitedHealth Stock performance.
Return On Equity | 0.25 | |||
Return On Asset | 0.0776 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 2.7 T | |||
Shares Outstanding | 65.4 B | |||
Price To Book | 6.68 X | |||
Price To Sales | 8.35 X | |||
Revenue | 322.13 B | |||
EBITDA | 31.84 B | |||
Total Debt | 54.51 B | |||
Book Value Per Share | 2.49 X | |||
Cash Flow From Operations | 26.21 B | |||
Earnings Per Share | 1.58 X | |||
Total Asset | 245.71 B | |||
About UnitedHealth Group Performance
By analyzing UnitedHealth Group's fundamental ratios, stakeholders can gain valuable insights into UnitedHealth Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if UnitedHealth Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if UnitedHealth Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about UnitedHealth Group performance evaluation
Checking the ongoing alerts about UnitedHealth Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for UnitedHealth Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.UnitedHealth Group generated a negative expected return over the last 90 days |
- Analyzing UnitedHealth Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UnitedHealth Group's stock is overvalued or undervalued compared to its peers.
- Examining UnitedHealth Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating UnitedHealth Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UnitedHealth Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of UnitedHealth Group's stock. These opinions can provide insight into UnitedHealth Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stocks Directory Find actively traded stocks across global markets |